15 November 2022
Director Retirement
Tony Balfour, who is due to retire by rotation at the next annual shareholder meeting (ASM), has advised of his intention not to seek re-election at the next ASM. Tony has been a director since 2020.
Blis Technologies Chair Geoff Plunket said: “Tony has made an outstanding contribution, bringing a wealth of international marketing and market development experience. Tony’s continued support through to the next ASM will be invaluable in assisting the Board and management to deliver the new Business to Business centric strategy. We will acknowledge Tony’s outstanding contribution at the ASM.”
Ends
For further information, please contact:
Geoff Plunket
Chair
+64 21 229 8886
About Blis Technologies Ltd
Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.
Website: www.blis.co.nz
Instagram: @blisprobiotics #blisk12 #blism18 #blisq24
Facebook: @BLISProbiotics
The NZX was flat, but property stocks declined more than 1%.
ANZ NZ styles its full-year results as solid as net-interest margin nudges higher.
Customer numbers for micro and rural payroll firm increased 9% for six months to Sept 30.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details